Actuate Therapeutics (ACTU) News
NASDAQ: ACTUHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.6102-0.0688 (-10.13%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ACTU news summary
We found 1 recent headline mentioning Actuate Therapeutics (ACTU): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. ACTU is making an outsized move today, down 10.13% at $0.6102, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "AbbVie's Temab-A Gets Two FDA Breakthrough Therapy Tags in Cancer", was published by Nasdaq on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology